{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T01:15:47Z","timestamp":1790471747386,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":1102,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1038\/mt.2013.144","type":"journal-article","created":{"date-parts":[[2013,6,14]],"date-time":"2013-06-14T07:16:51Z","timestamp":1371194211000},"page":"1898-1908","source":"Crossref","is-referenced-by-count":109,"title":["Toward RNAi Therapy for the Polyglutamine Disease Machado\u2013Joseph Disease"],"prefix":"10.1016","volume":"21","author":[{"given":"Maria","family":"do Carmo Costa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katiuska","family":"Luna-Cancalon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naila S","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahil M","family":"Dharia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Martin-Fishman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yemen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram G","family":"Shakkottai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly L","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgardo","family":"Rodr\u00edguez-Lebr\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry L","family":"Paulson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2013.144_bib1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.pneurobio.2011.11.006","article-title":"Toward understanding Machado-Joseph disease","volume":"97","author":"Costa","year":"2012","journal-title":"Prog Neurobiol"},{"key":"10.1038\/mt.2013.144_bib2","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.tins.2008.07.004","article-title":"Polyglutamine neurodegeneration: protein misfolding revisited","volume":"31","author":"Williams","year":"2008","journal-title":"Trends Neurosci"},{"key":"10.1038\/mt.2013.144_bib3","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000090035","article-title":"Population genetics of wild-type CAG repeats in the Machado-Joseph disease gene in Portugal","volume":"60","author":"Lima","year":"2005","journal-title":"Hum Hered"},{"key":"10.1038\/mt.2013.144_bib4","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1001\/archneur.58.11.1821","article-title":"Improvement in the molecular diagnosis of Machado-Joseph disease","volume":"58","author":"Maciel","year":"2001","journal-title":"Arch Neurol"},{"key":"10.1038\/mt.2013.144_bib5","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1212\/WNL.28.7.703","article-title":"Autosomal dominant system degeneration in Portuguese families of the Azores Islands. A new genetic disorder involving cerebellar, pyramidal, extrapyramidal and spinal cord motor functions","volume":"28","author":"Coutinho","year":"1978","journal-title":"Neurology"},{"key":"10.1038\/mt.2013.144_bib6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/WCO.0b013e3282f7673d","article-title":"New insights into the pathoanatomy of spinocerebellar ataxia type 3 (Machado-Joseph disease)","volume":"21","author":"R\u00fcb","year":"2008","journal-title":"Curr Opin Neurol"},{"key":"10.1038\/mt.2013.144_bib7","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1474-4422(04)00737-9","article-title":"Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis","volume":"3","author":"Sch\u00f6ls","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.1038\/mt.2013.144_bib8","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.tins.2011.05.004","article-title":"Balancing act: deubiquitinating enzymes in the nervous system","volume":"34","author":"Todi","year":"2011","journal-title":"Trends Neurosci"},{"key":"10.1038\/mt.2013.144_bib9","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature10671","article-title":"Excitation-induced ataxin-3 aggregation in neurons from patients with Machado-Joseph disease","volume":"480","author":"Koch","year":"2011","journal-title":"Nature"},{"key":"10.1038\/mt.2013.144_bib10","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0896-6273(00)80943-5","article-title":"Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3","volume":"19","author":"Paulson","year":"1997","journal-title":"Neuron"},{"key":"10.1038\/mt.2013.144_bib11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pneurobio.2011.06.007","article-title":"Polyglutamine diseases: the special case of ataxin-3 and Machado-Joseph disease","volume":"95","author":"Matos","year":"2011","journal-title":"Prog Neurobiol"},{"key":"10.1038\/mt.2013.144_bib12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1055\/s-2007-971172","article-title":"Dominantly inherited ataxias: lessons learned from Machado-Joseph disease\/spinocerebellar ataxia type 3","volume":"27","author":"Paulson","year":"2007","journal-title":"Semin Neurol"},{"key":"10.1038\/mt.2013.144_bib13","doi-asserted-by":"crossref","first-page":"26188","DOI":"10.1074\/jbc.M710521200","article-title":"Heat shock transcription factor 1-activating compounds suppress polyglutamine-induced neurodegeneration through induction of multiple molecular chaperones","volume":"283","author":"Fujikake","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2013.144_bib14","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1093\/hmg\/ddr203","article-title":"Neuron-specific proteotoxicity of mutant ataxin-3 in C. elegans: rescue by the DAF-16 and HSF-1 pathways","volume":"20","author":"Teixeira-Castro","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2013.144_bib15","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/hmg\/dds449","article-title":"Calpain-mediated ataxin-3 cleavage in the molecular pathogenesis of spinocerebellar ataxia type 3 (SCA3)","volume":"22","author":"H\u00fcbener","year":"2013","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2013.144_bib16","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1093\/brain\/aws177","article-title":"Calpastatin-mediated inhibition of calpains in the mouse brain prevents mutant ataxin 3 proteolysis, nuclear localization and aggregation, relieving Machado-Joseph disease","volume":"135","author":"Sim\u00f5es","year":"2012","journal-title":"Brain"},{"key":"10.1038\/mt.2013.144_bib17","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.nbd.2010.10.019","article-title":"HDAC inhibitor sodium butyrate reverses transcriptional downregulation and ameliorates ataxic symptoms in a transgenic mouse model of SCA3","volume":"41","author":"Chou","year":"2011","journal-title":"Neurobiol Dis"},{"key":"10.1038\/mt.2013.144_bib18","doi-asserted-by":"crossref","first-page":"13002","DOI":"10.1523\/JNEUROSCI.2789-11.2011","article-title":"Early changes in cerebellar physiology accompany motor dysfunction in the polyglutamine disease spinocerebellar ataxia type 3","volume":"31","author":"Shakkottai","year":"2011","journal-title":"J Neurosci"},{"key":"10.1038\/mt.2013.144_bib19","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.bbrc.2007.08.062","article-title":"Inactivation of the mouse Atxn3 (ataxin-3) gene increases protein ubiquitination","volume":"362","author":"Schmitt","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/mt.2013.144_bib20","doi-asserted-by":"crossref","first-page":"e3341","DOI":"10.1371\/journal.pone.0003341","article-title":"Allele-specific RNA silencing of mutant ataxin-3 mediates neuroprotection in a rat model of Machado-Joseph disease","volume":"3","author":"Alves","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1038\/mt.2013.144_bib21","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1093\/hmg\/ddq111","article-title":"Silencing ataxin-3 mitigates degeneration in a rat model of Machado-Joseph disease: no role for wild-type ataxin-3?","volume":"19","author":"Alves","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2013.144_bib22","doi-asserted-by":"crossref","first-page":"e52396","DOI":"10.1371\/journal.pone.0052396","article-title":"Silencing mutant ataxin-3 rescues motor deficits and neuropathology in Machado-Joseph disease transgenic mice","volume":"8","author":"N\u00f3brega","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1038\/mt.2013.144_bib23","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/embor.2008.31","article-title":"Lentivector-mediated rescue from cerebellar ataxia in a mouse model of spinocerebellar ataxia","volume":"9","author":"Torashima","year":"2008","journal-title":"EMBO Rep"},{"key":"10.1038\/mt.2013.144_bib24","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1515\/bc.2011.045","article-title":"Allele-selective inhibition of ataxin-3 (ATX3) expression by antisense oligomers and duplex RNAs","volume":"392","author":"Hu","year":"2011","journal-title":"Biol Chem"},{"key":"10.1038\/mt.2013.144_bib25","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nbt.1539","article-title":"Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAs","volume":"27","author":"Hu","year":"2009","journal-title":"Nat Biotechnol"},{"key":"10.1038\/mt.2013.144_bib26","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/hmg\/11.9.1075","article-title":"YAC transgenic mice carrying pathological alleles of the MJD1 locus exhibit a mild and slowly progressive cerebellar deficit","volume":"11","author":"Cemal","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2013.144_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/mt.2013.152","article-title":"Silencing mutant ATXN3 expression resolves molecular phenotypes in SCA3 transgenic mice","author":"Rodr\u00edguez-Lebr\u00f3n","year":"2013","journal-title":"Mol Therapy (this issue)"},{"key":"10.1038\/mt.2013.144_bib28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/mt.2008.231","article-title":"Artificial microRNAs as siRNA shuttles: improved safety as compared to shRNAs in vitro and in vivo","volume":"17","author":"Boudreau","year":"2009","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2013.144_bib29","doi-asserted-by":"crossref","first-page":"5868","DOI":"10.1073\/pnas.0801775105","article-title":"Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi","volume":"105","author":"McBride","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2013.144_bib30","first-page":"203","article-title":"Clinical, genetic and pathological aspects of Machado-Joseph disease","volume":"29","author":"Coutinho","year":"1981","journal-title":"J Genet Hum"},{"key":"10.1038\/mt.2013.144_bib31","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0168-0102(97)00056-4","article-title":"Machado-Joseph disease gene products carrying different carboxyl termini","volume":"28","author":"Goto","year":"1997","journal-title":"Neurosci Res"},{"key":"10.1038\/mt.2013.144_bib32","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s100380170060","article-title":"The genomic structure and expression of MJD, the Machado-Joseph disease gene","volume":"46","author":"Ichikawa","year":"2001","journal-title":"J Hum Genet"},{"key":"10.1038\/mt.2013.144_bib33","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1038\/mt.2011.219","article-title":"Preclinical safety of RNAi-mediated HTT suppression in the rhesus macaque as a potential therapy for Huntington's disease","volume":"19","author":"McBride","year":"2011","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2013.144_bib34","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/mt.2009.17","article-title":"Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington's disease mice","volume":"17","author":"Boudreau","year":"2009","journal-title":"Mol Ther"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616322560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616322560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T07:58:08Z","timestamp":1563177488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616322560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S1525001616322560"],"URL":"https:\/\/doi.org\/10.1038\/mt.2013.144","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}